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Abstract
Oxygen serves as an essential factor for oxidative stress, and it has been shown to be a mutagen in bacteria. While it is well
established that ambient oxygen can also cause genomic instability in cultured mammalian cells, its effect on de novo
tumorigenesis at the organismal level is unclear. Herein, by decreasing ambient oxygen exposure, we report a ,50%
increase in the median tumor-free survival time of p532/2 mice. In the thymus, reducing oxygen exposure decreased the
levels of oxidative DNA damage and RAG recombinase, both of which are known to promote lymphomagenesis in p532/2
mice. Oxygen is further shown to be associated with genomic instability in two additional cancer models involving the APC
tumor suppressor gene and chemical carcinogenesis. Together, these observations represent the first report directly testing
the effect of ambient oxygen on de novo tumorigenesis and provide important physiologic evidence demonstrating its
critical role in increasing genomic instability in vivo.
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Introduction
Oxygen is essential for aerobic life and its deficiency is
associated with disease. However, the dual nature of oxygen was
recently demonstrated using a cell model with disruption of a
gene critical for mitochondrial respiration [1]. While oxygen is
required for oxidative phosphorylation to generate ATP, it also
serves as the essential substrate for the generation of reactive
oxygen species (ROS) implicated in tumorigenesis. Conceptually,
oxygen toxicity, not bioenergetic efficiency, was initially proposed
as the evolutionary driving force in the symbiotic theory of the
mitochondrion [2]. Non-respiring cells have increased oxygen-
associated genomic DNA damage demonstrating that the
disposition of intracellular oxygen by the mitochondria plays an
important role in maintaining genomic stability [1]. Previous
studies have also suggested the important role of mitochondrial
respiration in preventing oxidative stress and decreasing the
incidence of cancer and other age-associated degenerative
diseases [3,4,5,6,7].
As the essential substrate for oxidative stress, ambient oxygen
could play an important role in DNA damage and cellular
senescence. Indeed, lowering the oxygen exposure of cultured cells
has been shown to decrease oxidative DNA damage and extend
cellular lifespan [1,8,9]. Physiological levels of oxygen have been
shown to be mutagenic in bacteria [10] and suggested to play an
important role in promoting renal cancer formation in vivo [11],
but whether ambient oxygen can directly affect de novo tumori-
genesis has not been demonstrated. Although experimental data in
this area remains sparse, epidemiologic analysis, adjusted for
confounding factors such as natural radiation, shows decreased
cancer incidence in human populations living at high altitude [12].
Such potentially important observations are difficult to interpret in
the absence of a specific mechanism because of the various
physiologic and genetic adaptations that can occur in humans
living in low oxygen environments [13,14]. Therefore, we decided
to test the effect of reducing ambient oxygen exposure on de novo
tumorigenesis and in vivo genomic instability, an important driver
in pathogenesis, using three well-defined cancer models. These
current observations serve as a first step to delineating the
mechanisms that may underlie the association between oxygen
exposure and cancer.
Materials and Methods
Ethics statement
Mice were bred and maintained in the approved animal
housing facility of the National Institutes of Health, and all animal
experiments were in accordance with the guidelines of the NIH
animal care and use committee. The NIH ACUC approval
identification number for this animal protocol is H-0126.
Antibodies and reagents
Antibodies used in the study are as follows: Rabbit polyclonal
RAG1 (K-20, Santa Cruz Biotechnology); monoclonal phospho-S-
139 histone H2AX (c-H2AX, clone JBW301, Millipore); mono-
clonal b-actin (AC-15, Sigma); rabbit monoclonal b-catenin (6B3)
and cyclin D1 (DCS6, Cell Signaling). Chemicals used in the study
are as follows: avidin-FITC; 7,12-dimethylbenz[a]anthracene
(DMBA); and phorbol 12-myristate 13-acetate (TPA) (all from
Sigma).
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The p53+/+ and p532/2 HCT116 human colon cancer cell
lines were provided by Bert Vogelstein, Johns Hopkins University,
and grown in McCoy’s 5A medium supplemented with 10% fetal
bovine serum containing penicillin/streptomycin [15].
Hypoxia chamber
A large hypoxia chamber (Coy Laboratory Product Inc.)
capable of accommodating multiple standard-sized mouse cages
with a live animal waste removal system was set at 10% O2,0 –
0.5% CO2, 30–70% humidity at room temperature. These
parameters were continuously monitored with internal and
external probes through a tele-alarm service (Rees Scientific). All
animal studies including endpoint determinations were performed
in accordance with the guidelines and approval of the NIH animal
care and use committee. In all animals used for tumor-free survival
studies, necropsies were performed and histopathologic diagnoses
confirmed by certified NIH veterinary pathologists.
p532/2 mouse cancer model
C57BL/6J background strain wild-type and p532/2 mice
(B6.129S2-Trp53
tm1Tyj/J) were obtained from Jackson Laboratory
and bred to obtain littermates. Mice were weaned in 21% oxygen
(normoxia, room air) prior to randomization to 10% (hypoxia) or
21% oxygen according to animal care guidelines. Mice were
closely monitored for any evidence of tumor or health deteriora-
tion. Animals were euthanized and necropsies performed when
any external mass exceeded 2 cm in its largest dimension or when
the mice became moribund.
APC
Min/+ mouse polyposis model
Five week-old male APC
Min/+ mice (C57BL/6J-ApcMin/J) were
obtained from Jackson Laboratory and maintained in 10% or 21%
oxygen for 14 wk prior to sacrifice. The lumen of the small
intestine was examined under a low power dissecting scope and
the polyp diameters were measured using a caliper [16].
Chemical skin carcinogenesis
Five-wk old female FVB mice (FVB/NJ, Jackson Laboratory)
were used for the two-stage chemical skin carcinogenesis model as
previously described [17]. DMBA at a dosage of 5 mg or 100 mgi n
200 ml of acetone was applied to the shaved back of the mice
followed 2 wk later by 12.5 mg TPA (twice a week) for 13 wk or
11 wk, respectively, prior to papilloma quantification. For the
tumor endpoint survival study, TPA was applied until the defined
endpoint of papilloma size(s) exceeding 2 cm in any dimension,
ulceration or rupture of tumor, moribound state, or death.
Blood oxygen saturation measurement
Arterial blood oxygen saturation was determined using a pulse
oximetry sensor (MouseOx
TM Oxymeter, STARR Life Sciences
Corp.) attached to the tail of 10% oxygen acclimated mice.
Oxygen saturation was converted to partial pressure (mm Hg) as
previously reported [18].
Physiological Measurements and Body Mass
Composition
Blood samples were collected in EDTA anti-coagulant tubes for
hematocrit measurements. The Bruker Minispec NMR analyzer
(Bruker Optics) was used to measure body composition of non-
anesthetized mice after up to 16 wk of 10% oxygen exposure
(,21 wk old) [19]. Average daily food intake was estimated by
weighing the standard mouse chow in each cage over at least 4 wk.
Xenograft tumor growth assay
Athymic nude mice (B6.Cg-Foxn1nu/J, Jackson Laboratory)
were subcutaneously injected with 10610
6 cells into each hind
limb and housed in the indicated oxygen condition. Tumor
dimensions were measured using a digital caliper two times a week
and volumes estimated as previously described (volume=(width
26
length)/2) [20].
Apoptosis Detection
Apoptotic cells were stained by the terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL) technique
using paraffin-embedded tissue sections (Histoserve, Inc.). Images
were captured using an Axioskop2 Plus fluorescence microscope
with Axiovision software (version 4.6) and apoptotic nuclei were
quantified.
Blood GSH and GSSG measurement
Blood from wild-type C57BL/6J mice in room air or acclimated
to 10% oxygen for at least 4 wk was collected in EDTA tubes and
used for GSH and GSSG measurement according to the
manufacturer’s protocol (BIOXYTECHH GSH/GSSG-412 kit,
OxiResearch). Absorbance signals were collected using the
Victor3 plate reader (PerkinElmer).
ROS measurement
Samples obtained from mice exposed to different oxygen
concentrations were handled as rapidly as possible. The thymus
tissue was gently dissociated into cell suspension (PBS) using
sequential filtration through a nylon mesh (Gelman Laboratory)
and a 40 mm cell strainer (BD Falcon) and further washed with
PBS to remove tissue debris. The isolated thymocytes were
counted, stained with 5 mM CM-H2DCFDA (Invitrogen) for
15 min at 37uC, and washed with PBS. DCF signal was collected
and analyzed using FACSCalibur and CELLQusest
TM software
(version 3.3, BD Biosciences).
8-oxoG visualization with avidin-FITC
Frozen tissue sections (10 mm) were fixed in 2% paraformalde-
hyde PBS, permeabilized in 0.2% Triton X-100 PBS, RNA
eliminated by RNase A (10 mg/ml) treatment for 1 hr at room
temperature, and incubated in avidin-FITC (,1:200, Sigma) as
previously described [21,22]. Three PBS washes (5 min each) were
performed between all steps. Vectashield mounting medium with
DAPI (Vector Laboratories) was used to coverslip the slides and
their images captured using an Axioskop2 Plus fluorescence
microscope with Axiovision software (version 4.6).
Genomic DNA 8-oxoG content measurement
Genomic DNA from tissues was isolated using the DNeasy kit
(Qiagen) and 8-oxoG content determined using an ELISA kit
according to manufacturer’s protocol (8-OHdG Check Ultrasensi-
tive ELISA, Multispecies Specificity, BioVendor). Absorbance
signals were collected using the Victor3 plate reader (PerkinElmer).
Telomere length measurement
Telomere length using 10 ng of purified genomic DNA was
determined by a PCR-based technique as previously described
[23]. Ct values of the telomeric repeats and of the single-copy
acidic ribosomal phosphoprotein PO (36B4) gene were determined
using SYBR Green real-time PCR on a 7900HT Sequence
Detection System (Applied Biosystems) [23,24]. Relative telo-
mere length was determined by the ratio of telomere to 36B4 Ct
values.
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F: 59 CGG TTT GTT TGG GTT TGG GTT TGG
GTT TGG GTT TGG GTT 39
R: 59 GGC TTG CCT TAC CCT TAC CCT TAC
CCT TAC CCT TAC CCT 39
36B4 primers:
F: 59 ACT GGT CTA GGA CCC GAG AAG 39
R: 59 TCA ATG GTG CCT CTG GAG ATT 39
Western blotting
Tissues were homogenized in cold RIPA protein lysis buffer
with protease inhibitor cocktail and frozen on dry ice for storage.
Protein samples were heated for 5 min at 95uC prior to resolving
and transferring in Novex Tris-Glycine gel and XCell II
TM blot
module (Invitrogen), respectively. Membranes were incubated
overnight with primary antibody at 4uC and developed with HRP-
conjugated secondary antibody (,1:10,000, Jackson Laboratory)
using standard protocols.
Quantification of HIF1-a activity by target mRNA
expression
mRNA levels of the HIF1-a target genes VEGF and LDHA were
measured by RT-PCR and normalized to a housekeeping gene
TIF mRNA as previously described [24].
VEGF primers
F: 59-GTACTTGCAGATGTGACAAGCC-39
R: 59-GGGTGTGTCTACAGGAATCC-39
LDHA primers
F: 59- TGGCAGACTTGGCTGAGAGC-39
R: 59- GGTGTGGTCTGCCTAGAAGC-39
Statistical analysis
P values were calculated using Student’s t-test as indicated.
Kaplan-Meier survival analyses were performed using the Prism 4
software (GraphPad Software, Inc.).
Results
Ambient oxygen increases DNA damage and promotes
tumorigenesis in p532/2 mice
To test the concept of ambient oxygen as a tumor promoter, we
placed tumor-prone p53 deficient (p532/2) mice with defective
DNA damage response in free-living chronic hypoxia chambers
(10% oxygen, equivalent to ,5,000 meters above sea level). All
animals were housed in normoxic conditions (room air, ,21%
oxygen) until weaning, at which time some remained in normoxia
and others were transferred to hypoxia. The decreased oxygen
exposure, even after earlier life in normoxia, resulted in a ,50%
longer median tumor-free survival time compared to animals that
remained in normoxia (33 versus 22 weeks, respectively,
P,0.0001) (Figure 1A). This survival data provided physiologic
evidence that ambient oxygen can indeed promote tumorigenesis
in a setting of reduced genomic protection such as found in
p532/2 mice.
We first confirmed that tissue oxygenation is indeed decreased
by hypoxia but that it is adequate to supply general metabolic
needs. Notably, the partial pressure of oxygen in arterial blood was
reduced by 50% as would be predicted from the magnitude of
reduction in ambient oxygen (from 21% to 10%) while the
hematocrit level was increased confirming chronic adaptation to
hypoxia (Figure 1B and Figure S1) [25]. The correspondence
between the relative reduction in arterial blood oxygenation and
ambient oxygen level was consistent with previously published
direct measurements of tissue oxygen concentration in animals
[25], and it also suggested that the adaptive changes were sufficient
to meet the metabolic requirements of mice in 10% oxygen
following acclimation. Furthermore, no significant physiological
changes were noted between the 10% and 21% oxygen conditions,
as assessed by body weight, body mass composition and food
intake, indicating that the animals were in overall good health
before cancer development (Figure S2).
We next sought to provide an explanation for the improved
tumor-free survival under the mildly low oxygen condition. It is
formally possible that the decreased oxygen concentration in the
hypoxia chamber could bioenergetically limit the growth of cancer
cells by decreasing oxidative phosphorylation. To test this
possibility, we examined the growth rate of the established human
colon cancer HCT116 cells as xenografts in 10% versus 21%
oxygen. The xenograft growth rates were similar indicating that
the in vivo proliferation of established cancer cells is not inhibited
by a lower ambient oxygen level and thus does not serve to explain
the increased tumor-free survival in hypoxia (Figure 1C). As the
p53 deficient state may influence tumor growth in hypoxia, we
also measured the xenograft growth of p532/2 HCT116 cells. As
previously observed, p532/2 cells appeared to grow more rapidly
compared to isogenic p53+/+ cells [15], but their growth rates
were also not affected by the tested ambient oxygen levels
(Figure 1D).
During the course of our study, the majority of p532/2 mice
in 21% oxygen developed thymic lymphomas as previously
described [26]. No qualitative differences could be detected in the
incidence of lymphoma that developed under the different
oxygen conditions as assessed by histological appearance,
presence of apoptotic nuclei, or metastasis (Figure S3A and
S3B). However, it was notable that in the 10% versus 21%
oxygen condition, there was a decreased trend of lymphoma
development and an increased trend for non-lymphoma tumors
which were histologically confirmed to ensure that they were not
metastatic thymic lymphomas (Figure S3C). One explanation for
this phenomenon could be that lowering oxygen exposure delays
lymphomagenesis and that the subsequent increase in lifespan
allows for the emergence of other types of tumors that otherwise
would not have been observed. In support of this notion, most of
the non-lymphoma tumors (78%) occurred in mice that survived
beyond 6 months, the typical lifespan of p532/2 mice in
normoxia.
Our current observation of increased tumor-free survival under
reduced ambient oxygen in p532/2 mice appeared to be
inconsistent with the observation that hypoxia, through HIF1-a
for example, may promote the growth of cancer cells [27]. This
suggested that we were observing a fundamentally different aspect
of tumorigenesis compared to the studies using established cancer
cell lines by in vitro or xenografts assays which reflect the
proliferation of cancer cells. Because ambient oxygen can cause
oxidative DNA damage in vitro [1], it could also initiate
tumorigenesis through an increase in genomic instability in vivo.
Thus, we hypothesized that reduced oxygen exposure might result
in lower levels of oxidative stress and genomic DNA damage in a
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lymphomagenesis.
Glutathione is the major free radical scavenger and an
important marker of oxidative stress. To show that mice exposed
to a lower ambient oxygen level had less oxidative stress, we
measured both reduced (GSH) and oxidized (GSSG) glutathione
in blood of mice chronically adapted to 10% oxygen. The GSH
concentration increased by 43% in the 10% oxygen condition
compared to room air while there was no significant difference in
GSSG levels within the detection limits of the assay (Figure 2A).
This increase in GSH, which is mostly contained in erythrocytes
[28], could not be fully explained by the 23% increase in
hematocrit after hypoxic adaptation (Figure S1), suggesting that
physiologic hypoxia reduces oxidative stress and increases
antioxidant capacity. Furthermore, we observed a decrease in
ROS levels by DCF staining of cells dissociated from the thymus of
mice chronically adapted to 10% versus 21% oxygen (Figure 2B).
Consistent with these findings of reduced oxidative stress under
relatively mild hypoxia, we observed a significant reduction in
avidin-FITC staining, which detects oxidatively modified DNA
base 8-oxoguanine (8-oxoG), in the thymus of p532/2 mice
chronically adapted to hypoxia prior to the overt development of
lymphoma (Figure 2C). The quantification of 8-oxoG by
immunoassay using genomic DNA prepared from thymus tissue
confirmed the increase in oxidative DNA damage visualized by
avidin-FITC in 21% oxygen (Figure 2C and 2D).
Oxidative stress has also been associated with telomere
shortening [29] and dysfunctional telomerase has been linked
to the increased incidence of cancer in p532/2 mice [30].
Conversely, the low oxygen niche of hematopoietic stem cells
has been associated with increased telomerase activity [31].
Concordant with these observations, the genomic DNA of
thymus tissue showed significant oxygen-associateds h o r t e n i n g
of telomere length as another marker of DNA damage and
genomic instability (Figure 2E). Furthermore, a recent study has
revealed that blocking T cells at stages of high recombination-
activating gene (RAG) activity accelerates lymphomagenesis in
p532/2 mice [32] while the absence of RAG1 significantly
increases the latency of lymphomagenesis in p53 inactivated
states [33]. Therefore, we examined whether oxygen might
influence RAG expression in the thymus. In 10% oxygen, there
was a significant decrease in the level of RAG1 protein
expression compared to 21% oxygen. Together, these observa-
tions suggested that oxygen can cause genomic instability
through more than one mechanism such as that involving
RAG, which is known to cause DNA double-strand breaks in
the setting of deficient DNA damage response (Figure 2F) [32].
Although we have not shown that one specific pathway causally
explains our tumor-free survival data, the observation of
decreased genomic instability under the low oxygen condition
using three different markers strongly suggests its involvement in
this phenomenon.
Figure 1. Ambient oxygen promotes tumorigenesis in p532/2 mice. A. p532/2 mice show increased median tumor-free survival time in
10% compared to 21% ambient oxygen by Kaplan-Meier survival analysis. After weaning in 21% oxygen (normoxia, room air), the p532/2 mice either
remained in normoxia or were transferred to standard-sized mouse cages in a large 10% oxygen (hypoxia) chamber. Tumor-free survival period was
defined as time to death with tumor diagnosis at necropsy or to an external tumor exceeding 2 cm in any dimension per institutional animal care and
use committee guidelines (10% oxygen, n=20; 21% oxygen, n=14). B. Arterial oxygen saturation is proportional to ambient oxygen after acclimation
indicating absence of significant supply-demand mismatch (partial pressure of oxygen, PO2). Data are shown as mean 6 SEM, with n=5. C.
Decreased ambient oxygen does not inhibit the growth of p53+/+ HCT116 cancer cell as xenografts. 10610
6 cells were injected into the contra-lateral
hind limbs of athymic nude mice and immediately placed in their respective ambient oxygen conditions. Xenograft tumor growth was monitored
over the time as shown (n=10 each). D. Decreased ambient oxygen does not inhibit the growth of p532/2 HCT116 cancer cell as xenografts (n=10
each).
doi:10.1371/journal.pone.0019785.g001
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locus and promotes polyp formation in APC
Min/+ mice
To further expand on our initial observation that oxygen
promotes genomic instability and tumorigenesis, we examined the
effect of ambient oxygen on the APC
Min/+ mouse model of
intestinal neoplasia wherein the inactivation of the wild-type APC
allele initiates the formation of polyps [34,35]. Thus, polyp
formation serves as a functional readout of genomic instability.
Five weeks after birth, APC
Min/+ mice were placed in 10% oxygen
and their intestines assessed for polyp formation after 14 wk (age
,19 wk). We observed a significant reduction in the total number
of intestinal polyps under lower oxygen compared to the room air
condition (Figure 3A). When the size distribution of the intestinal
polyps was examined, the number of smaller polyps appeared to
be more significantly affected by changes in oxygen exposure
(Figure 3B). The relative difference in the number of polyps in
10% versus 21% ambient oxygen was greater for smaller diameter
polyps (,1.5 mm and 1.5,2 mm) while there was no significant
difference in larger polyps (.2 mm) (Figure 3C). One interpre-
tation of this data is that the larger, likely older, polyps were
Figure 2. Lowering oxygen exposure reduces oxidative stress, DNA damage and genomic instability in thymus. A. Changes in
reduced (GSH) and oxidized (GSSG) glutathione levels show increased antioxidant capacity in blood of mice after chronic adaptation to the 10%
oxygen condition. Data shown as mean 6 SEM, with n=4. B. Decreased ROS levels measured by DCF FACS in cells isolated from the thymus of mice
in 10% oxygen. Data shown as mean 6 SEM, with n=5. C. Representative images of decreased oxidative DNA damage detected by avidin-FITC (Av-
FITC) staining for 8-oxoG in thymus tissue from p532/2 mouse exposed to 10% versus 21% oxygen for 2 to 4 wk. Nuclei counterstaining with DAPI
show similar densities in the tissue. Scale bar, 100 mm (originally 636magnification). D. Decreased oxidative DNA damage quantified by 8-oxoG
enzyme-linked immunosorbent assay (ELISA) in thymus tissue from p532/2 mice exposed to 10% compared to 21% oxygen. Absolute value of 8-
oxoG (pg/mg genomic DNA) shown as mean 6 SEM, with n=3. E. Increased relative telomere length measured by RT-PCR of genomic DNA from
thymus tissue of p532/2 mice exposed to 10% versus 21% oxygen. Data shown as mean 6 SEM, with n=3. F. Decreased RAG1 protein level
measured by western blotting in 10% versus 21% oxygen. Samples shown are from two separate animals in each oxygen condition and b-actin serves
as protein loading control.
doi:10.1371/journal.pone.0019785.g002
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groups of mice were exposed to the same room air condition and
therefore were similar in number. In contrast, the smaller polyps,
likely representing more recently initiated polyps after reduced
oxygen exposure, displayed the largest relative difference
(Figure 3C). Thus, this well-defined model served to functionally
demonstrate that ambient oxygen is involved in promoting the
polyp formation by affecting genomic stability at the wild-type
APC gene locus.
As with the p532/2 mouse thymus tissue, we also measured
the levels of oxidatively modified genomic DNA in the small
intestines of the APC
Min/+ mouse. Even in segments of intestine
appearing normal, reduced ambient oxygen resulted in signifi-
cantly lower 8-oxoG DNA levels that were paralleled by the
decreased DNA damage response marker c-H2AX (Figure 4A and
4B). As APC mediates the degradation of cytoplasmic b-catenin,
reduced inactivation of the APC locus in 10% oxygen would be
expected to result in decreased b-catenin levels along with its
transcriptional target cyclin D1 that is involved in cell proliferation
[36]. Indeed, tissue levels of both b-catenin and cyclin D1 protein
were reduced in 10% oxygen, consistent with the decrease in polyp
formation (Figure 4D).
Ambient oxygen is involved in initiating chemical skin
carcinogenesis
Hypoxia causes physiologic adaptations to improve tissue
oxygenation such as the observed increase in hematocrit.
However, the oxygen in the superficial layer of the skin is largely
supplied by direct exposure to air so that tissue oxygenation can be
more predictably altered by changing ambient oxygen conditions
[37]. To minimize the effects of systemic adaptations to hypoxia,
we used the two-stage chemical skin carcinogenesis model in
which the topical application of the tumor initiating mutagen
DMBA is followed by longer term treatment with phorbol esters
(TPA).
Under the 10% oxygen condition, there was a marked
reduction in the formation of skin papillomas at both the standard
(5 mg) and high (100 mg) dose of DMBA (Figure 5A and 5B). Using
the standard DMBA dose, the median survival time to reach our
predetermined endpoint (measured by skin tumor size and burden)
was significantly delayed from 26 wk in 21% oxygen to 35 wk in
10% oxygen (P=0.003, Figure 5C). This significant increase in
median survival time using a cancer model that is different from
the p532/2 mouse further confirmed the pro-tumorigenic effect
of oxygen. Here, we also examined whether the oxidative
modification of genomic DNA was affected by oxygen exposure
in the skin. Compared to controls, DMBA caused a significant
increase in the level of oxidatively modified genomic DNA that
was highly dependent on 21% ambient oxygen (Figure 5D). The
application of TPA did not alter the level of DNA damage,
consistent with its proliferative and non-mutagenic mechanism of
action. Furthermore, the levels of the DNA damage response
protein c-H2AX closely paralleled the 8-oxo-G measurements in
the respective tissue samples (Figure 5E).
Figure 3. Ambient oxygen promotes tumorigenesis in APC
Min/+ mice. A. Significant decrease in the total number of small intestinal polyps
per mouse in 19 wk old APC
Min/+ mice that were placed in 10% versus 21% oxygen for 14 wk, starting at 5 wk of age. Data shown as mean 6 SEM,
with n=12. B. Decreased smaller diameter polyps (black arrowheads) in representative intestinal segments from mice in 10% compared to 21%
oxygen. C. Quantification of polyps classified by size (polyp diameter, mm) in 10% versus 21% oxygen. The relative reduction in polyp number in 10%
versus 21% oxygen is greatest for the smallest diameter polyps (,1.5 mm). Data shown as mean 6 SEM, with n=12.
doi:10.1371/journal.pone.0019785.g003
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By reducing ambient oxygen exposure in three separate de novo
cancer models, our study shows the potential importance of
oxygen in influencing the initiation of tumorigenesis. Although
large human epidemiologic datasets have correlated exposure to
higher altitudes with lower cancer incidence, our study provides
the first controlled demonstration that lower ambient oxygen levels
delay tumorigenesis, independent of other variables such as
barometric pressure and ultraviolet exposure associated with high
altitude [12]. Our data also provide physiological evidence for the
critical role of oxidative stress in increasing genomic instability, an
essential driver in the multi-step process of tumorigenesis [38].
Most importantly, our study provides proof of concept that it is
possible to alter the time course of tumor development by the
simple modulation of ambient oxygen, the essential factor for
oxidative stress.
We have previously shown that increased intracellular oxygen
levels caused by the disruption of mitochondrial function may
contribute to increased ROS generation and genomic DNA
damage [1]. Thus, the current in vivo data support the in vitro
observation that oxygen consumption via mitochondrial respira-
tion may serve a fundamentally important function to guard
against oxygen-associated genotoxicity. A previous study has
reported that the antioxidant N-acetyl cysteine (NAC) can delay
tumorigenesis in p53-deficient mice, underscoring the importance
of p53’s antioxidant activities in tumor suppression [22,39]. Our
study provides important complementary data to validate this
prior observation which used a pharmacologic agent. Further-
more, the current study is unique in that through a physiological
manipulation, we have demonstrated the importance of oxygen in
modulating genomic instability.
Although our results show that lowering oxygen reduces
genomic instability and tumorigenesis in vivo, hypoxic conditions
in various systems have also been shown to promote tumor cell
growth through HIF1-a induction [27,40]. Conversely, established
cancer cells engineered to over-express myoglobin, thus containing
higher intracellular oxygen and lower HIF1-a levels, exhibit a
decrease in xenograft tumor growth [41]. However, in our
experiments tissues obtained from mice exposed to 10% oxygen
did not show a significant increase in HIF1-a activity at this level
of physiologically adaptable hypoxia (Figure S4). Thus, our
observations are more likely to stem from a delay in tumor
initiation due to reduced genomic instability in low oxygen rather
than reflect the growth activities known to be stimulated by HIF1-
a in established tumor cells.
Supraphysiologic levels of oxygen, including hyperbaric condi-
tions, have been shown to inhibit tumorigenesis [42,43]. However,
oxidative stress responses such as p53 stabilization may contribute
to inhibiting tumor growth [44,45]. As demonstrated by many
elegant studies, ROS plays multiple roles depending on various
factors. ROS as a signaling molecule is necessary for cell
proliferation [46], but at higher levels it can also induce cell death
and prevent tumor growth [47]. Together with these observations,
our results reveal the complexity of tumorigenesis and the dual
nature of oxygen. Oxygen can promote cancer initiation by
increasing genomic instability through oxidative stress while also
having the potential to inhibit the growth of established tumor cells
through specific signaling mechanisms [41].
The lessons from our current study may be applicable to human
health. Supplemental oxygen is ubiquitously employed in clinical
medicine because of its immediate benefits for energy production
while the less apparent potential for genotoxicity can be neglected.
Our work may provide a biological mechanism for important
Figure 4. Lowering oxygen exposure prevents DNA damage and b-catenin accumulation in the intestine. A. Decreased oxidative DNA
damage as measured by 8-oxoG (pg/mg genomic DNA) ELISA in polyp-free segments of intestine from 10% compared to 21% oxygen APC
Min/+ mice.
Data shown as mean 6 SEM, with n=3. B. Decreased DNA damage response observed by c-H2AX western blotting in polyp-free intestine of 10%
compared to 21% oxygen APC
Min/+ mice. Relative intensity quantified by densitometric scanning of c-H2AX normalized to b-actin protein (graph),
n=3.C. Decreased protein levels of b-catenin and its transcriptional target cyclin D1 in polyp-free intestine of 10% compared to 21% oxygen APC
Min/+
mice. Representative samples in each oxygen condition and b-actin serves as protein loading control, n=3.
doi:10.1371/journal.pone.0019785.g004
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exposed to supplemental oxygen or of babies conceived through in
vitro fertilization, which may be performed under 21% oxygen
whereas the oxygen concentration in the uterus is 5- to 10-fold
lower [48,49,50,51]. Although it is difficult to control for the many
variables that are associated with the requirement for oxygen
therapy, our experiments reveal the potential genotoxicity of
oxygen which may be more immediately relevant to the clinics.
Thus, minimizing oxygen exposure at early developmental stages
such as in neonates or of in vitro fertilized oocytes prior to uterine
implantation may potentially decrease the risk of cancer over a
lifetime. Similarly, although antioxidants do not appear to have
Figure 5. Ambient oxygen promotes chemical skin carcinogenesis. A. Decreased skin papilloma formation using the two-stage chemical skin
carcinogenesis model in 10% compared to 21% ambient oxygen. Representative images are shown for standard (5 mg) or high (100 mg) topical dose
of DMBA followed by chronic TPA application. B. Decreased papilloma number per mouse in 10% compared to 21% oxygen. Data shown as mean 6
SEM, with n=10 to 15. C. Increased median survival time to tumor endpoint in 10% compared to 21% oxygen by Kaplan-Meier survival analysis. The
standard dose of DMBA followed by chronic TPA application was used until the defined tumor endpoint of papilloma size(s) exceeding 2 cm in any
dimension, significant ulceration or rupture of tumor, moribound state, or death. 10% oxygen, n=10; 21% oxygen, n=10. D. Decreased oxidative
DNA damage quantified by 8-oxoG ELISA in DMBA treated skin tissue of mice in 10% compared to 21% oxygen. DMBA (100 mg) and TPA (12.5 mg)
were applied according to skin per protocol, animals were exposed to the indicated oxygen conditions, and skin tissue was harvested prior to the
development of papillomas at 7 wk. Absolute value of 8-oxoG (pg/mg genomic DNA) shown as mean 6 SEM, with n=3. E. Confirmation of decreased
DNA damage by protein levels of c-H2AX in skin tissue from treated mice in 10% compared to 21% oxygen. b-actin serves as protein loading control
and samples are shown from two separate animals for each condition as duplicates.
doi:10.1371/journal.pone.0019785.g005
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PLoS ONE | www.plosone.org 8 May 2011 | Volume 6 | Issue 5 | e19785tumor suppressive effects in the general population [52,53],
targeting individuals who have specific inherited cancer suscepti-
bility syndromes due to defects in DNA repair to strategies of
reducing oxygen exposure or antioxidant therapy may yield
marked benefits.
Supporting Information
Figure S1 Blood hematocrit is increased after chronic adapta-
tion to 10% oxygen. Data are shown as mean 6 SEM, with n=6
to 9.
(TIF)
Figure S2 No significant difference in body weight, body mass
composition or food intake in the 10% versus 21% oxygen
condition. A. Body weights of male and female p532/2 mice in
10% oxygen versus 21% oxygen are shown over time. Mice with
evidence of tumor were excluded. Note that the body weights of
the 10% oxygen group span a longer period due to longer tumor-
free survival time (n=4 to 17 in each group). B. Body mass
composition (% muscle, fat or free fluid of total body weight) was
measured in non-anesthetized mice that were housed in 10% or
21% oxygen for up to 16 wk. Data are shown as mean 6 SEM,
with n=3. C. Average food intake per day (g/d) by each mouse
measured over a 4 wk period. Data are shown as mean 6 SEM,
with n=5.
(TIF)
Figure S3 Lymphoma characteristics of p532/2 mice in 10%
versus 21% ambient oxygen. A. Representative images of TUNEL
stained thymic lymphoma show no significant differences in
apoptosis between 10% and 21% oxygen conditions. The
arrowheads indicate positively stained cells. Right panel shows
the quantification of apoptotic nuclei per high power field in 5 to
10 separate regions. Data are shown as mean 6 SEM, with n=3.
Scale bar, 20 mm (originally 406magnification). B. No significant
difference in the fraction of mice with metastatic lymphoma as
determined by necropsy (10% oxygen, n=20; 21% oxygen,
n=14). C. There is a trend of increased incidence of non-
lymphoma tumors in 10% compared to 21% ambient oxygen
condition (10% oxygen, n=20; 21% oxygen, n=14).
(TIF)
Figure S4 Expression levels of HIF1-a target genes are not
significantly increased in 10% versus 21% oxygen. The relative
levels of VEGF and LDHA mRNA as markers of HIF1-a activity
were measured in liver, spleen and thymus of p532/2 mice. Mice
were acclimated to 10% oxygen for at least 2 to 4 wk prior to
tissue harvest. Data are shown as mean 6 SEM, with n=3.
(TIF)
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